189
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Preferred Practice Patterns of Congenital Nasolacrimal Duct Obstruction in Jordan

ORCID Icon, , ORCID Icon, , ORCID Icon, , , & show all
Pages 2309-2322 | Received 12 May 2023, Accepted 23 Jun 2023, Published online: 11 Aug 2023

References

  • Olitsky SE. Update on congenital nasolacrimal duct obstruction. Int Ophthalmol Clin. 2014;54(3):1–7. doi:10.1097/IIO.0000000000000030
  • Petersen RA, Robb RM. The natural course of congenital obstruction of the nasolacrimal duct. J Pediatr Ophthalmol Strabismus. 1978;15(4):246–250. doi:10.3928/0191-3913-19780701-14
  • Moscato EE, Kelly JP, Weiss A. Developmental anatomy of the nasolacrimal duct: implications for congenital obstruction. Ophthalmology. 2010;117(12):2430–2434. doi:10.1016/j.ophtha.2010.03.030
  • Aldahash FD, Al-Mubarak MF, Alenezi SH, et al. Risk factors for developing congenital nasolacrimal duct obstruction. Saudi J Ophthalmol. 2014;28(1):58–60. doi:10.1016/j.sjopt.2013.09.007
  • Schellini SA, Ariki CT, Sousa RLF, et al. Management of congenital nasolacrimal duct obstruction--Latin American study. Ophthalmic Plast Reconstr Surg. 2013;29(5):389–392. doi:10.1097/IOP.0b013e31829bb162
  • MacEwen CJ, Young JD. Epiphora during the first year of life. Eye. 1991;5(Pt 5):596–600. doi:10.1038/eye.1991.103
  • Lorena SH, Silva JA, Scarpi MJ. Congenital nasolacrimal duct obstruction in premature children. J Pediatr Ophthalmol Strabismus. 2013;50(4):239–244. doi:10.3928/01913913-20130423-01
  • Bekmez S, Eriş E, Altan EV, et al. The role of bacterial etiology in the tear duct infections secondary to congenital nasolacrimal duct obstructions. J Craniofac Surg. 2019;30(7):2214–2216. doi:10.1097/SCS.0000000000005798
  • Schellini SA, Hoyama E, Rocha MC, et al. Evaluation of lacrimal system outflow in the newborn by dye tests. Orbit. 2000;19(3):137–142. doi:10.1076/orbi.19.3.137.2662
  • Takahashi Y, Kakizaki H, Chan WO, et al. Management of congenital nasolacrimal duct obstruction. Acta Ophthalmol. 2010;88(5):506–513. doi:10.1111/j.1755-3768.2009.01592.x
  • Kakizaki H, Takahashi Y, Kinoshita S, Shiraki K, Iwaki M. The rate of symptomatic improvement of congenital nasolacrimal duct obstruction in Japanese infants treated with conservative management during the 1st year of age. Clin Ophthalmol. 2008;2(2):291–294. doi:10.2147/OPTH.S2582
  • Repka MX, Chandler DL, Beck RW, et al. Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years. Ophthalmology. 2008;115(3):577–584.e3.
  • Young JD, MacEwen CJ, Ogston SA. Congenital nasolacrimal duct obstruction in the second year of life: a multicentre trial of management. Eye. 1996;10(Pt 4):485–491. doi:10.1038/eye.1996.107
  • Saniasiaya J, Abdullah B, Husain S, et al. Primary endoscopic endonasal dacryocystorhinostomy for pediatric nasolacrimal duct obstruction: a systematic review. Am J Rhinol Allergy. 2017;31(5):328–333. doi:10.2500/ajra.2017.31.4464
  • Engel JM, Hichie-Schmidt C, Khammar A, et al. Monocanalicular silastic intubation for the initial correction of congenital nasolacrimal duct obstruction. J Aapos. 2007;11(2):183–186. doi:10.1016/j.jaapos.2006.09.009
  • Eysenbach G. Improving the quality of web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res. 2004;6(3):e34. doi:10.2196/jmir.6.3.e34
  • Alsaad M, Shehadeh A. Knowledge, attitude, and practice of different specialties about congenital nasolacrimal duct obstruction: a cross- sectional study in Jordan. Int Med J. 2019;24:1.
  • Alkilany M. Jordanian ophthalmologists plan regional YO chapter; 2020. Available from: https://www.aao.org/young-ophthalmologists/yo-info/article/jordanian-yos-plan-regional-chapter. Accessed August 8, 2023.
  • World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194. doi:10.1001/jama.2013.281053
  • Bansal O, Bothra N, Sharma A, et al. Congenital nasolacrimal duct obstruction update study (CUP study): paper I-role and outcomes of Crigler’s lacrimal sac compression. Eye. 2021;35(6):1600–1604. doi:10.1038/s41433-020-01125-1
  • Bothra N, Ali MJ. Congenital nasolacrimal duct obstruction update study (CUP Study): paper 4-Infantile Acute Dacryocystitis (InAD)-presentation, management, and outcomes. Ophthalmic Plast Reconstr Surg. 2022;38(3):270–273. doi:10.1097/IOP.0000000000002077
  • Kushner BJ. Congenital nasolacrimal system obstruction. Arch Ophthalmol. 1982;100(4):597–600. doi:10.1001/archopht.1982.01030030599010
  • Rees MG, Woo CL, Optom B. Pediatric eye disease investigator group amblyopia treatment review. Am Orthopt J. 2007;57:99–103. doi:10.3368/aoj.57.1.99
  • Kapadia MK, Freitag SK, Woog JJ. Evaluation and management of congenital nasolacrimal duct obstruction. Otolaryngol Clin North Am. 2006;39(5):959–77, vii. doi:10.1016/j.otc.2006.08.004
  • Kashkouli MB, Kassaee A, Tabatabaee Z. Initial nasolacrimal duct probing in children under age 5: cure rate and factors affecting success. J Aapos. 2002;6(6):360–363. doi:10.1067/mpa.2002.129041
  • Honavar SG, Prakash VE, Rao GN. Outcome of probing for congenital nasolacrimal duct obstruction in older children. Am J Ophthalmol. 2000;130(1):42–48. doi:10.1016/S0002-9394(00)00388-3
  • Komínek P, Červenka S, Pniak T, et al. Monocanalicular versus bicanalicular intubation in the treatment of congenital nasolacrimal duct obstruction. Graefes Arch Clin Exp Ophthalmol. 2011;249(11):1729–1733. doi:10.1007/s00417-011-1700-2
  • Andalib D, Gharabaghi D, Nabai R, et al. Monocanalicular versus bicanalicular silicone intubation for congenital nasolacrimal duct obstruction. J Aapos. 2010;14(5):421–424. doi:10.1016/j.jaapos.2010.08.003
  • Michael A, Kipp RCA. Congenital Nasolacrimal duct obstruction (NLDO); 2023. Available from: https://www.aao.org/education/oculoplastics-center/congenital-nasolacrimal-duct-obstruction-nldo. Accessed August 8, 2023.
  • Grover AK. Management of nasolacrimal duct obstruction in children: how is it changing? Indian J Ophthalmol. 2017;65(10):910–911. doi:10.4103/ijo.IJO_719_17
  • Leibovitch I, Selva D, Tsirbas A, et al. Paediatric endoscopic endonasal dacryocystorhinostomy in congenital nasolacrimal duct obstruction. Graefes Arch Clin Exp Ophthalmol. 2006;244(10):1250–1254. doi:10.1007/s00417-006-0273-y
  • Nowinski TS, Flanagan JC, Mauriello J. Pediatric Dacryocystorhinostomy. Arch Ophthalmol. 1985;103(8):1226–1228. doi:10.1001/archopht.1985.01050080138035
  • Ramkumar VA, Agarkar S, Mukherjee B. Nasolacrimal duct obstruction: does it really increase the risk of amblyopia in children? Indian J Ophthalmol. 2016;64(7):496–499. doi:10.4103/0301-4738.190101
  • Silbert DI, Matta NS, Quintanal A, et al. Incidence of amblyopia risk factors in children with nasolacrimal duct obstruction. J AAPOS. 2013;17(6):618. doi:10.1016/j.jaapos.2013.06.019
  • Ellis JD, MacEwen CJ, Young JD. Can congenital nasolacrimal-duct obstruction interfere with visual development? A cohort case control study. J Pediatr Ophthalmol Strabismus. 1998;35(2):81–85. doi:10.3928/0191-3913-19980301-05